✦ LIBER ✦

Histopathological assessment of anastrozole and tamoxifen as preoperative (neoadjuvant) treatment in postmenopausal Japanese women with hormone receptor-positive breast cancer in the PROACT trial

✍ Scribed by Masafumi Kurosumi; Yuichi Takatsuka; Toru Watanabe; Shigeru Imoto; Hideo Inaji; Hitoshi Tsuda; Futoshi Akiyama; Goi Sakamoto; Tadashi Ikeda; Shinzaburo Noguchi

Book ID: 118297416
Publisher: Springer-Verlag
Year: 2007
Tongue: English
Weight: 357 KB
Volume: 134
Category: Article
ISSN: 1432-1335
DOI: 10.1007/s00432-007-0343-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Anastrozole versus tamoxifen as neoadjuv

Anastrozole versus tamoxifen as neoadjuvant therapy for oestrogen receptor-positive breast cancer in postmenopausal women: the IMPACT and PROACT trials

✍ I Smith; L Cataliotti 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 331 KB

Efficacy of pre-operative Arimidex (anas

Efficacy of pre-operative Arimidex (anastrozole) compared with tamoxifen (PROACT) as neoadjuvant therapy in postmenopausal women with hormone receptor-positive breast cancer

✍ L Cataliotti; A Buzdar; S Noguchi; J Bines 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 162 KB

Comparison of anastrozole versus tamoxif

Comparison of anastrozole versus tamoxifen as preoperative therapy in postmenopausal women with hormone receptor-positive breast cancer : The pre-operative “Arimidex” compared to Tamoxifen (PROACT) trial

✍ Luigi Cataliotti; Aman U. Buzdar; Shinzaburo Noguchi; Jose Bines; Yuichi Takatsu 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 193 KB 👁 2 views

## Abstract ## BACKGROUND The Pre‐Operative “Arimidex” Compared to Tamoxifen (PROACT) study was a randomized, multicenter study comparing anastrozole with tamoxifen as a preoperative treatment of postmenopausal women with large, operable (T2/3, N0‐2, M0), or potentially operable (T4b, N0‐2, M0) br

0181 PROACT: A randomised study comparin

0181 PROACT: A randomised study comparing anastrozole with tamoxifen as neoadjuvant and adjuvant treatment in postmenopausal women with locally advanced breast cancer - a Japanese subgroup analysis

✍ S. Imoto; Y. Takatsuka; Y. Fujiwara; H. Inaji; T. Ikeda; L. Cataliotti; A. Buzda 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 51 KB

A randomized trial exploring the biomark

A randomized trial exploring the biomarker effects of neoadjuvant sequential treatment with exemestane and anastrozole in post-menopausal women with hormone receptor-positive breast cancer

✍ O. C. Freedman; E. Amir; W. Hanna; H. Kahn; F. O’Malley; G. Dranitsaris; D. E. C 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 257 KB

A randomized trial of combination anastr

A randomized trial of combination anastrozole plus gefitinib and of combination fulvestrant plus gefitinib in the treatment of postmenopausal women with hormone receptor positive metastatic breast cancer

✍ Robert W. Carlson, Anne O’Neill, Tatiana Vidaurre, Henry L. Gomez, Sunil S. Badv 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 275 KB